Cancer Center– A Cancer Center Designated by
the National Cancer Institute

Clinical Trials in the Category "Breast Neoplasms"

Drug Intervention Trials that are Recruiting

Study Title
 Principal Investigator Disease Category
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Irene L. Wapnir
 Breast Cancer
Carcinoma, Intraductal, Noninfiltrating
Phase II Gemcitabine, Carboplatin & PARP Inhibitor BSI-201 in Neoadjuvant Tx of Triple-Neg Breast CA Allison Walsh Kurian
 Breast Cancer
Ph I/II of Vitamin D on Bone Mineral Density & Markers of Bone Resorption Eva Balint
Robert W Carlson
 Breast Cancer
Bone Diseases
Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries Amreen Husain
 Ovarian Cancer
Osteoporosis
Breast Cancer
Development of Vitamin D as a Therapy for Breast Cancer - Phase II Robert W Carlson
 Breast Cancer
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer Robert W Carlson
 Breast Cancer
Phase II Trial - Breast Cancer Chemoprevention by Lovastatin James M Ford
 Breast Cancer
Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic Breast Dr. Ellie Guardino MD/PhD
 Breast Cancer
Phase II Gemzar, Taxol & Avastin Combination as 1st Line Tx for Metastatic Breast CA Dr. Ellie Guardino MD/PhD
 Breast Cancer
Phase II Anastrozole and ZD6474 in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer Dr. Ellie Guardino MD/PhD
 Breast Cancer
Phase II Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel with Lapatinib in Stage II/III Her2Neu+ Breast Cancer Dr. Ellie Guardino MD/PhD
 Breast Cancer
Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer Irene L. Wapnir
 Breast Cancer
Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer Irene L. Wapnir
 Breast Cancer
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) Irene L. Wapnir
 Breast Cancer

Device Intervention Trials that are Recruiting

Study Title
 Principal Investigator Disease Category
Survey of Optical Measures of Breast Tissue in the Clinic Debra M Ikeda
 Breast Cancer
Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status Stanley G Rockson
 Breast Cancer
Lymphedema

Other Trials that are Recruiting

Study Title
 Principal Investigator Disease Category
Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Irene L. Wapnir
 Breast Cancer
Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors Kate R Lorig
 Breast Cancer
Prostatic Neoplasms
Colorectal Neoplasms
Anal, Colon, and Rectal Cancers
Blood Cancer
Immunobiology of Breast Cancer Peter P Lee
 Breast Cancer
18 F-fluoride PET/CT versus 99Tc-MDP Scanning for Detecting Bone Metastases Sanjiv Sam Gambhir M.D., Ph.D.
 Breast Cancer
Prostatic Neoplasms
Bone Cancer
Lung Cancer
Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT Irene L. Wapnir
 Breast Cancer
Breast Density and the Role of Preoperative Mammography, Ultrasound, Elastography and MRI Debra M Ikeda
 Breast Cancer
A Pilot Study Evaluating the Immunologic Status of Patients with HER2+ Breast Cancer Dr. Ellie Guardino MD/PhD
 Breast Cancer
Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer Irene L. Wapnir
 Breast Cancer
Healing Touch during Chemotherapy Infusions for Women with Breast Cancer Kathy Turner RN, NP
Dr. Ellie Guardino MD/PhD
 Breast Cancer
Molecular Analysis of Breast Cancer Stefanie S. Jeffrey M.D.
 Breast Cancer
Sleep, Circadian Hormonal Dysregulation, and Breast Cancer Survival David Spiegel
 Breast Cancer
Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample Irene L. Wapnir
 Breast Cancer
Salivary Gland Neoplasms
Stomach Cancer
Thyroid Cancer

Trials not Recruiting

Study Title
 Principal Investigator Disease Category
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
(No longer recruiting) 		Irene L. Wapnir
 Breast Cancer
Intellectual Impairment in Women With Breast Cancer
(Not yet recruiting) 		Shelli Kesler
 Breast Cancer
A Phase I/II Study of HKI-272 in Combination With Paclitaxel in Subjects With Advanced Solid Tumors and Breast Cancer
(No longer recruiting) 		Branimir I Sikic
 Breast Cancer
Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2
(No longer recruiting) 		Stanley G Rockson
 Breast Cancer
Lymphedema
Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer
(No longer recruiting) 		Frederick M. Dirbas
 Breast Cancer
Carcinoma, Ductal
Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer
(No longer recruiting) 		James M Ford
 Breast Cancer
Scintigraphic Assessment of I- Transport in Metastatic Breast Cancer and Evaluation of I31I Ablative Therapy: (Part I) Radioiodide Imaging Study
(Completed) 		Irene L. Wapnir
 Breast Cancer
Estradiol Suppression for the treatment of metastatic breast cancer in premenopausal women
(No longer recruiting) 		Robert W Carlson
 Breast Cancer
Stress, Diurnal Cortisol, and Breast Cancer Survival
(No longer recruiting) 		David Spiegel
 Breast Cancer
Anastrozole and Gefitinib Compared With Fulvestrant and Gefitinib in Treating Postmenopausal Women With Recurrent or Metastatic Breast Cancer
(No longer recruiting) 		Robert W Carlson
 Breast Cancer
A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2)
(No longer recruiting) 		Robert W Carlson
 Breast Cancer
Effect of Healing Touch on the Experience of Women Undergoing Treatment for Breast Cancer
(Completed) 		Lynn m Westphal
 Breast Cancer
A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Metastatic Breast Cancer
(No longer recruiting) 		Dr. Ellie Guardino MD/PhD
 Breast Cancer


The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials.  Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials.

Stanford Medicine Resources:

Footer Links: